natgillin/translations-raw huggingface dataset:
7 - 14 days Most patients with pneumonia were switched to oral treatment with Avalox tablets within 4 days. 
7 - 14 dni Večina bolnikov s pljučnico je prešla na peroralno zdravljenje s tabletami Avalox v 4 dneh.
Bayer Santé 13, rue Jean Jaurès 92807 Puteaux Cedex 
Bayer Santé 13, rue Jean Jaurès 92807 Puteaux Cedex Francija
Do not use Avalox after the expiry date which is stated on the label on the bottle bag and carton. 
Zdravilo Avalox ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki na steklenici vreči in škatli.
Avalox is for intravenous use. 
Zdravilo Avalox je za intravensko uporabo.
This medicinal product is authorised in the Member States of the EEA under the following names: 
Zdravilo je v državah članicah EGP pridobilo dovoljenje za promet z naslednjimi imeni: Avstrija:
Avelox United Kingdom: Avelox 
Avelox Velika Britanija Avelox
Like all medicines, Avalox can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi zdravilo Avalox neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
- If you or any member of your family have glucose-6-phosphate dehydrogenase deficiency (a rare hereditary disease), inform your doctor, who will advise whether Avalox is suitable for you. 
Če imate vi ali katerikoli član vaše družine pomanjkanje glukoza-6-fosfat dehidrogenaze (redko prirojeno bolezen), o tem obvestite svojega zdravnika, ki vam bo svetoval ali je zdravilo Avalox primerno zdravilo za vas.
WHAT AVALOX IS AND WHAT IT IS USED FOR 
KAJ JE ZDRAVILO AVALOX IN ZA KAJ GA UPORABLJAMO
1000 Ljubljana Slovenia 
Bravničarjeva 13 1000 Ljubljana Slovenija
Do not use Avalox - If you are allergic (hypersensitive) to the active ingredient moxifloxacin, any other quinolone antibiotics or any of the other ingredients (see section 6. 
Ne uporabljajte zdravila Avalox - če ste alergični (preobčutljivi) na zdravilno učinkovino moksifloksacin, druge kinolone ali katerokoli sestavino (glejte poglavje 6.
Important information about some of the ingredients of Avalox This medicinal product contains 787mg (approximately 34mmol) sodium per dose. 
Pomembne informacije o nekaterih sestavinah zdravila Avalox To zdravilo vsebuje 787 mg (približno 34 mmolov) natrija na odmerek.
Nervous System Common: 
Živčni sistem Pogosti:
Your doctor will decide on the duration of your treatment with Avalox. 
Vaš zdravnik se bo odločil koliko časa bo trajalo zdravljenje z zdravilom Avalox.
Avalox is used in adults for treating the following bacterial infections: - Infection of the lungs (pneumonia) acquired outside the hospital - Infections of the skin and soft tissue 
Zdravilo Avalox se pri odraslih uporablja za zdravljenje naslednjih bakterijskih okužb: pljučnice (pnevmonije), pridobljene izven bolnišnice, okužbe kože in mehkih tkiv.
Using Avalox with food and drink The effect of Avalox is not influenced by food including dairy products. 
Uporaba zdravila Avalox skupaj s hrano in pijačo Hrana (vključno z mlečnimi izdelki) ne vpliva na učinke zdravila Avalox.
Avalox is a clear, yellow solution for infusion. 
Zdravilo Avalox je bistra, rumena raztopina za infundiranje.
In some cases your doctor may start your treatment with Avalox solution for infusion and then continue your treatment with Avalox tablets. 
V nekaterih primerih lahko zdravnik začne zdraviti z raztopino za infundiranje Avalox in nadaljuje zdravljenje s tabletami Avalox.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines besides Avalox, including medicines obtained without a prescription. 
Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Avalox will always be given to you by a doctor or healthcare professional. 
KAKO UPORABLJATI ZDRAVILO AVALOX Zdravilo Avalox vam bo vedno dal zdravnik ali zdravstveno osebje.
- Avalox should be given intravenously (in the vein) only, and should not be administered into an artery. 
Zdravilo se daje samo intravensko (v veno) in ne v arterijo.
“Complicated skin and skin structure infections only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection (see section 4.4)” 
„Zapletene okužbe kože in mehkih tkiv, le ko uporaba protibakterijskih učinkovin, ki jih ponavadi priporočajo za začetno zdravljenje teh okužb (glejte poglavje 4.4), ni primerna.“
What Avalox looks like and contents of the pack 
Izgled zdravila Avalox in vsebina pakiranja
If you stop using Avalox 
Če ste prenehali uporabljati zdravilo Avalox
What Avalox is and what it is used for Before you use Avalox How to use Avalox Possible side effects How to store Avalox Further information 
Kaj je zdravilo Avalox in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Avalox Kako uporabljati zdravilo Avalox Možni neželeni učinki
You should avoid prolonged exposure to sunlight or strong sunlight and should not use a sunbed or any other UV lamp while taking Avalox. 
Med uporabo zdravila Avalox se morate izogibati daljšemu izpostavljanju sončni svetlobi ali močni sončni svetlobi in ne smete uporabljati solarija ali drugih UV svetilk.
Intravenous moxifloxacin was not associated with an increased incidence of events that would be considered surrogates for a QTcrelated arrhythmia. 
Intravenozni moksifloksacin ni bil povezan s povečano pojavnostjo dogodkov, ki bi lahko bili nadomestki za aritmijo, povezano s QTc.
Avalox contains moxifloxacin as the active ingredient which belongs to a group of antibiotics called fluoroquinolones. 
Zdravilo Avalox vsebuje zdravilno učinkovino moksifloksacin, ki spada v skupino antibiotikov, imenovano fluorokinoloni.
Avalox works by killing bacteria that cause infections if they are caused by bacteria that are susceptible to moxifloxacin. 
Zdravilo Avalox uničuje bakterije, ki povzročajo okužbe in so občutljive za moksifloksacin.
Before using Avalox for the first time - Avalox can temporarily change your heart's ECG, which can very rarely lead to life-threatening disturbances of the heart rhythm. 
Zdravilo Avalox lahko začasno vpliva na vaš EKG srca, ki lahko v zelo redko privede do življensko ogrožujoče motnje srčnega ritma.
- Avalox may cause a rapid and severe inflammation of the liver which could lead to lifethreatening liver failure (including fatal cases, see section 4. 
Zdravilo Avalox lahko povzroči nenadno in hudo vnetje jeter, kar lahko povzroči življenjsko ogrožajočo jetrno odpoved (vključno s smrtnimi primeri) (glejte poglavje 4.
- Special care is need if you are taking other medicines that can lower your blood potassium levels or cause a slow heart rate because these can also increase the risk of serious heart rhythm disturbances while taking Avalox. 
Posebna pozornost je potrebna, če jemljete druga zdravila, ki lahko zmanjšajo vrednosti kalija ali upočasnijo srčni utrip, ker to lahko poveča tveganje za pojav hudih motenj srčnega ritma med jemanjem zdravila Avalox.
The frequency of possible side effects listed below is defined using the following convention: Very common: affects more than 1 user in 10 
Pogostnost spodaj navedenih možnih neželenih učinkov je navedena kot sledi: Zelo pogosti:
Consult your doctor if you wish to stop the treatment with Avalox solution for infusion or Avalox tablets before the end of the course of treatment. 
Posvetujte se s svojim zdravnikom, če želite prenehati uporabljati raztopino za infundiranje Avalox ali tablete Avalox pred zaključkom zdravljenja, posebno s poznejšim jemanjem tablet.
Emotional instability, depression (in very rare cases leading to self-harm), 
čustvena labilnost, depresija (v zelo redkih primerih samoogrožajoče vedenje), halucinacije
Belgium Bayer SA-NV Avenue Louise 143 
Bayer SA-NV Avenue Louise 143 Louizalaan
Moxifloxacin undergoes Phase II biotransformation and is excreted via renal (approximately 40%) and biliary/faecal (approximately 60%) pathways as unchanged drug as well as in the form of a sulpho-compound (M1) and a glucuronide (M2). 
fazi, izloča pa se s sečem (približno 40 %) in žolčem/blatom (približno 60 %), in sicer kot nespremenjeno zdravilo, pa tudi v obliki žveplove spojine (M1) in glukuronida (M2).
Avalox should not be co-infused with other drugs. 
Zdravilo Avalox ne smete infundirati hkrati z drugimi zdravili.
The following side effects have been observed during treatment with Avalox. 
V nadaljevanju so našteti neželeni učinki, ki so jih opazili med zdravljenjem z zdravilom Avalox.
Furthermore, there have been very rare cases of the following side effects reported following treatment with other quinolone antibiotics, which might possibly also occur during treatment with Avalox: transient loss of vision, increased blood sodium levels, increased blood calcium levels, increased breakdown of red blood cells, muscle reactions with muscle cell damage, increased sensitivity of the skin to sunlight or UV light. 
V zelo redkih primerih so po zdravljenju z drugimi kinolonskimi antibiotiki poročali o naslednjih neželenih učinkih, ki se lahko prav tako pojavijo tudi med zdravljenjem z zdravilom Avalox: prehodna izguba vida, zvečane vrednosti natrija v krvi, zvečane vrednosti kalcija v krvi, povečan razpad eritrocitov, mišične spremembe s poškodbo mišičnih celic, povečana občutljivost kože za sončno ali UV svetlobo.
Finally, the Applicant claimed that the superior potency and pharmacokinetics of moxifloxacin avoids the selection of quinolone resistant isolates of S. pneumoniae. 
Na koncu je predlagatelj trdil, da se z večjo učinkovitostjo in farmakokinetiko moksifloksacina izognemo izbiri izolatov S. pneumnoiae, odpornih na kinolone.
- There is limited experience on use of sequential intravenous/oral Avalox for the treatment of infection of the lungs (pneumonia) acquired outside the hospital. 
Izkušnje z uporabo zdravila Avalox (sekvenčno intravensko/peroralno) pri zdravljenju pljučnice (pnevmonije), pridobljene izven bolnišnice, so omejene.
- If you suffer from myasthenia gravis using Avalox may worsen the symptoms of your disease. 
Če imate miastenijo gravis, lahko jemanje zdravila Avalox poslabša znake vaše bolezni.
If the blood supply to your heart muscle is impaired, consult your doctor before you are given Avalox because this can increase the risk of heart rhythm disturbances. 
Če je oskrba vašega srca s krvjo motena, se posvetujte s svojim zdravnikom preden vzamete zdravilo Avalox, ker to lahko poveča tveganje za pojav motenj srčnega ritma.
Avalox is packaged in cartons containing a 250ml glass bottle with a chlorobutyl rubber stopper. 
Zdravilo Avalox je pakirano v škatle, ki vsebujejo 250 ml steklenice s klorobutilnim gumijastim zamaškom.
- The efficacy of Avalox in the treatment of severe burns, infections of deep tissue, major purulent ulcers (abscesses) and diabetic foot infections with osteomyelitis (infections of the bone marrow) has not been established. 
Učinkovitost zdravila Avalox pri zdravljenju opeklin, okužb globokih tkiv, obsežnejših gnojnih razjed (abscesov) in okužb diabetične noge z osteomielitisom (okužba kostnega mozga) ni dokazana.
If this happens treatment with Avalox solution for infusion has to be discontinued immediately. 
Če se to pojavi, je treba takoj prenehati uporabljati raztopino za infundiranje Avalox.
the CHMP has recommended the amendment of the Summary of Product Characteristics and the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Avalox and associated names (see Annex I). 
CHMP je priporočil dopolnitev povzetka glavnih značilnosti zdravila in odobritev dovoljenj za promet z zdravilom Avalox in z njim povezanimi imeni (glejte Dodatek I), katerih povzetek glavnih značilnosti zdravila, označevanje in navodila za uporabo so navedeni v Dodatku III.
In conclusion, the CHMP accepts that moxifloxacin may be indicated for the treatment of CAP, however the data it must be remembered that safety and benefitrisk were the main concerns triggering the referral and therefore, the conclusion that moxifloxacin has acceptable efficacy must be placed into context. 
CHMP se naposled strinja, da je moksifloksacin lahko indiciran za zdravljenje izvenbolnišnično pridobljene pljučnice, vendar se ne sme pozabiti, da sta bila varnost in razmerje med koristmi in tveganji glavna zadržka, ki sta sprožila napotitveni postopek, zato je treba to upoštevati pri ugotovitvi, da je moksifloksacin sprejemljivo učinkovit,
If you receive more Avalox than you should If you are concerned that you may have been received too much Avalox, contact your doctor immediately. 
Če ste dobili večji odmerek zdravila Avalox, kot bi smeli Če menite, da ste dobili preveč zdravila Avalox, se takoj posvetujte z zdravnikom.
- If you suffer from epilepsy or a condition which makes you likely to have convulsions, tell your doctor before taking Avalox. 
Če imate epilepsijo ali stanja, ki povzročajo krče, o tem pred začetkom jemanja zdravila Avalox obvestite svojega zdravnika.
If this becomes severe or persistent or you notice that your stool contains blood or mucus you should stop taking Avalox immediately and consult your doctor. 
Če se pojavi huda in trdovratna driska ali če v blatu opazite kri ali sluz, se posvetujte s svojim zdravnikom, ker je treba takoj prenehati uporabljati zdravilo Avalox.
The frequencies of cardiac adverse events and adverse events were similar and the post-marketing observational studies and post-marketing surveillance of spontaneous adverse events do not show any evidence that IV/oral moxifloxacin is associated with a significantly higher risk of developing liver or cardiac adverse events than standard therapy. 
Pogostost neželenih učinkov, povezanih s srcem, in neželenih učinkov na splošno je bila podobna, opazovalne študije po začetku trženja in nadzor spontanih neželenih učinkov po začetku trženja pa nikakor ne dokazujejo, da je intravenozno/peroralno zdravljenje z moksifloksacinom v primerjavi s standardnim zdravljenjem povezano z bistveno višjim tveganjem za nastanek neželenih učinkov, povezanih z jetri in srcem.
increase of a special liver enzyme in the blood (LDH)), increase of bilirubin in the blood, increase of a special liver enzyme in the blood (gamma-glutamyl-transferase and/or alkaline phosphatase) 
jetrna okvara (tudi zvečane vrednosti posebnih jetrnih encimov v krvi (LDH)), zvečane vrednosti bilirubina v krvi, zvečane vrednosti posebnih jetrnih encimov v krvi (gamaglutamiltransferaze in/ali alkalne fosfataze)
Therefore, do not take the following medicines during treatment with Avalox: Medicines that belong to the group of anti-arrhythmics (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), neuroleptics (e.g. phenothiazines, pimozide, sertindole, haloperidol, sultopride), tricyclic antidepressants, some antimicrobials (e.g. sparfloxacin, intravenous erythromycin, pentamidine, antimalarials particularly halofantrine), some antihistamines (e.g. terfenadine, astemizole, mizolastine), and other medicines (e.g. cisapride, intravenous vincamine, bepridil and diphemanil). 
Med zdravljenjem z zdravilom Avalox ne jemljite sočasno naslednja zdravila: zdravila, ki spadajo v skupino antiaritmikov (npr. kinidin, hidrokinidin, dizopiramid, amiodaron, sotalol, dofetilid, ibutilid), nevroleptike (npr. fenotiazini, pimozid, sertindol, haloperidol, sultoprid), triciklične antidepresive, nekatera protimikrobna zdravila (npr. sparfloksacin, intravenska oblika eritromicina, pentamidin, antimalariki, predvsem halofantrin), nekatere antihistaminike (npr. terfenadin, astemizol, mizolastin) in druga zdravila (npr. cisaprid, intravenska oblika vinkamina, bepridil, difemanil).
There have been very rare cases of the following side effects reported following treatment with other fluoroquinolones, which might possibly also occur during treatment with moxifloxacin: transient loss of vision, hypernatraemia, hypercalcaemia, haemolysis, rhabdomyolysis, photosensitivity reactions (see section 4.4). 
Med zdravljenjem z drugimi fluorokinoloni so poročali o zelo redkih primerih naslednjih neželenih učinkov, ki bi se prav tako lahko pojavili tudi med zdravljenjem z moksifloksacinom: prehodna izguba vida, hipernatriemija, hiperkalciemija, hemoliza, rabdomioliza, fotosenzitivne reakcije (glejte poglavje
Contains sodium chloride, hydrochloric acid (for pH-adjustment), sodium hydroxide (for pHadjustment) and water for injections. 
Vsebuje natrijev klorid, klorovodikovo kislino (za uravnavanje pH), natrijev hidroksid (za uravnavanje pH) in vodo za injekcije.
When using Avalox - The risk of cardiac abnormalities may increase with the dose and the speed of the infusion into your vein. 
Tveganje za srčne nepravilnosti se lahko poveča z odmerkom in hitrostjo infuzije v vašo veno.
A feeling of self-detachment (not being yourself), insanity (potentially leading to self harm) 
Zelo redki: motnja samozavedanja (nezavedanje samega sebe), duševna zmedenost (potencialno samoogrožajoče vedenje)
The following solutions were incompatible with Avalox: Sodium chloride 10% and 20% solutions, Sodium bicarbonate 4.2% and 8.4% solutions 
Z zdravilom Avalox so bile inkompatibilne naslednje raztopine: 10 % in 20 % raztopina natrijevega klorida, 4,2 % in 8,4 % raztopina natrijevega karbonata
For Avalox be aware of the following: - If you are taking other medicines that affect your heart during treatment with Avalox there is an increased risk for altering your heart rhythm. 
Če med zdravljenjem z zdravilom Avalox jemljete druga zdravila, ki vplivajo na srce, obstaja povečano tveganje za spremembe srčnega ritma.
Avalox can be administered via a T-tube together with the following solutions: Water for injections, sodium chloride 0.9%, sodium chloride 1 molar, glucose 5%/10%/40%, Xylitol 20%, Ringer's solution, compound sodium lactate solution (Hartmann's solution, Ringer-lactate solution). 
Zdravilo Avalox lahko dajete s pomočjo T-cevke skupaj z naslednjimi raztopinami: voda za injekcije, 0,9 % raztopina natrijevega klorida, 1 molarna raztopina natrijevega klorida, 5 %/10 %/40 % raztopina glukoze, 20 % raztopina ksilitola, Ringerjeva raztopina, sestavljena raztopina natrijevega laktata (Hartmannova raztopina, raztopina Ringerjevega laktata).
An analysis of cardiac safety in sequential IV/oral clinical studies (overall and cSSSIs) was presented, along with an overview of the incidence of treatment-emergent adverse events relevant as surrogates for arrhythmia. 
Predstavili so analizo varnosti srca v kliničnih študijah zaporednega intravenoznega/peroralnega zdravljenja (na splošno in pri zapletenih okužbah kože in mehkih tkiv), skupaj s pregledom pojavnosti neželenih učinkov, ki zahtevajo nujno zdravljenje, pomembnih kot nadomestki pri aritmiji.
- If you experience palpitations or irregular heart beat during the period of treatment, you should stop taking Avalox and inform your doctor immediately. 
Če imate med zdravljenjem palpitacije ali nepravilen srčni utrip, prenehajte z jemanjem zdravila Avalox in o tem takoj obvestite svojega zdravnika.
Take special care with Avalox 
Bodite posebno pozorni pri uporabi zdravila Avalox
- If you are currently taking any medicine that decreases your blood potassium levels, consult your doctor before taking Avalox because this can increase the risk of heart rhythm disturbances. 
Če jemljete druga zdravila, ki zmanjšajo vrednost kalija v krvi, se posvetujte s svojim zdravnikom preden vzamete zdravilo Avalox, ker to lahko poveča tveganje za pojav motenj srčnega ritma.
The Applicant discussed the efficacy and safety of sequential IV/oral moxifloxacin in the treatment of cSSSI and concluded that non-inferiority was demonstrated, and that the clinical studies and postmarketing safety data show no evidence that moxifloxacin-treated patients are at greater risk for morbidity, including cardiac and hepatic morbidity, than patients receiving comparator antibiotics. 
Zdravljenje zapletenih okužb kože in mehkih tkiv Predlagatelj je razpravljal o učinkovitosti in varnosti zaporednega intravenoznega / peroralnega zdravljenja zapletenih okužb kože in mehkih tkiv z moksifloksacinom in zaključil, da so dokazali neinferiornost ter da klinične študije in podatki o varnosti po začetku trženja ne dajejo nobenih dokazov, da bi imeli bolniki, zdravljeni z moksifloksacinom, večje tveganje obolevnosti, vključno z obolevnostjo srca in jeter, kot bolniki, ki prejemajo primerjalne antibiotike.
- You may develop diarrhoea whilst taking, or after taking, antibiotics including Avalox. 
Med ali po jemanju antibiotikov (tudi zdravila Avalox) se lahko pojavi driska.
Germany Bayer Vital GmbH Kaiser Wilhelm Allee 51368 Leverkusen Germany 
Bayer Vital GmbH Kaiser Wilhelm Allee 51368 Leverkusen Nemčija
Avalox is packaged in cartons containing 250ml polyolefine bags with polypropylene port sealed in aluminium foil overwrap. 
Zdravilo Avelox je pakirano v škatle, ki vsebujejo 250 ml poliolefinske vreče s polipropilensko zaporko in omot iz aluminija.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, 
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Bayer HealthCare AG Kaiser Wilhelm Allee 51368 Leverkusen Germany 
Bayer HealthCare AG Kaiser Wilhelm Allee 51368 Leverkusen Nemčija
Cross resistance should be expected between moxifloxacin andother fluoroquinolones. 
Med moksifloksacinom in drugimi fluorokinoloni se lahko pričakuje navzkrižno odpornost.
If you miss a dose of Avalox If you are concerned that you may have missed a dose of Avalox, contact your doctor immediately. 
Če niste dobili odmerek zdravila Avalox Če menite, da niste dobili odmerek zdravila Avalox, se takoj posvetujte z zdravnikom.
(Invented) Name Strength Pharmaceutical Form 
Izmišljeno ime Ime
Increase of a special liver enzyme in the blood (gamma-glutamyl-transferase) Uncommon: Abnormal fast heart rate, low blood pressure, swelling (of the hands, feet, ankles, lips, mouth, throat), severe diarrhoea containing blood and/or mucus (antibiotic associated colitis) which in very rare circumstances, may develop into complications that are life-threatening, convulsions, hallucination, kidney impairment (incl. 
nenormalen hiter srčni ritem, znižan krvni tlak, otekline (rok, stopal, gležnjev, ustnic, ust in grla), huda driska, ki vsebuje kri in/ali sluz (kolitis, povezan z antibiotičnim zdravljenjem), ki se v zelo redkih primerih lahko razvije v smrtno nevarne zaplete, krči, halucinacije, motnje v delovanju ledvic (tudi zvečane vrednosti posebnih ledvičnih laboratorijskih testov; sečnine in kreatinina), ledvična odpoved
What Avalox contains 
Kaj vsebuje zdravilo Avalox
For reasons of drug safety, moxifloxacin is therefore contraindicated in patients with: - Congenital or documented acquired QT prolongation - Electrolyte disturbances, particularly in uncorrected hypokalaemia - Clinically relevant bradycardia - Clinically relevant heart failure with reduced left-ventricular ejection fraction - Previous history of symptomatic arrhythmias Moxifloxacin should not be used concurrently with other drugs that prolong the QT interval (see also section 4.5). 
Zaradi varnostnih razlogov je uporaba moksifloksacina kontraindicirana pri bolnikih s/z: prirojenim ali dokazano pridobljenim podaljšanjem intervala QT, motnjami elektrolitskega ravnotežja, zlasti z nezdravljeno hipokaliemijo, klinično pomembno bradikardijo, klinično pomembnim srčnim popuščanjem in zmanjšano iztisno frakcijo levega prekata, simptomatskimi aritmijami v anamnezi.
Avalox and associated names (see Annex I) 400mg/250ml solution for infusion 
Avalox in povezana imena (Glejte Dodatek I) 400 mg/250 ml raztopina za infundiranje